Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis.
Anne J PaccalyMichael R MigdenKyriakos P PapadopoulosFeng YangJohn D DavisRonda K RippleyIsrael LowyMatthew G FuryElizabeth StankevichDanny RischinPublished in: Advances in therapy (2021)
Cemiplimab 350 mg Q3W is being further investigated in multiple indications.
Keyphrases